Analyst Downgrades – Atara Biotherapeutics (NASDAQ:ATRA) Stock Gets Downgraded By Citigroup from Neutral to Sell

0

Analyst Ratings For Atara Biotherapeutics (NASDAQ:ATRA)

Today, Atara Biotherapeutics (NASDAQ:ATRA) stock was downgraded by Citigroup from Neutral to Sell.

Some recent analyst ratings include

  • 2/15/2018-Citigroup was Downgraded by analysts at Citigroup from a “Neutral ” rating to a ” Sell” rating.
  • 1/26/2018-Cowen initiated coverage with a Outperform rating.
  • 1/19/2018-Canaccord Genuity Reiterated Rating of Buy .
  • 10/6/2017-Goldman Sachs Group Reiterated Rating of Neutral .
  • 10/5/2017-Jefferies Group Reiterated Rating of Buy.
  • 6/26/2017-William Blair Reiterated Rating of Outperform.
  • 7/9/2016-JMP Securities Reiterated Rating of Buy.

Recent Insider Trading Activity For Atara Biotherapeutics (NASDAQ:ATRA)
Atara Biotherapeutics (NASDAQ:ATRA) has insider ownership of 16.20% and institutional ownership of 69.58%.

  • On 2/14/2018 Isaac E Ciechanover, CEO, sold 20,000 with an average share price of $46.80 per share and the total transaction amounting to $936,000.00.
  • On 2/9/2018 Heather D Turner, EVP, sold 12,214 with an average share price of $38.01 per share and the total transaction amounting to $464,254.14.
  • On 2/9/2018 Isaac E Ciechanover, CEO, sold 8,800 with an average share price of $37.44 per share and the total transaction amounting to $329,472.00.
  • On 1/26/2018 Isaac E Ciechanover, CEO, sold 19,300 with an average share price of $35.26 per share and the total transaction amounting to $680,518.00.
  • On 1/24/2018 Isaac E Ciechanover, CEO, sold 48,500 with an average share price of $34.58 per share and the total transaction amounting to $1,677,130.00.
  • On 1/22/2018 Isaac E Ciechanover, CEO, sold 10,000 with an average share price of $33.07 per share and the total transaction amounting to $330,700.00.
  • On 1/16/2018 Isaac E Ciechanover, CEO, sold 600 with an average share price of $30.38 per share and the total transaction amounting to $18,228.00.

Recent Trading Activity for Atara Biotherapeutics (NASDAQ:ATRA)
Shares of Atara Biotherapeutics closed the previous trading session at 47.30 down -1.05 2.17% with 42.849998474121094 shares trading hands.

An ad to help with our costs